Fact Sheet for Healthcare Providers: Aptima ® SARS-CoV-2 assay – Hologic, Inc.

Source: U.S. Food and Drug Administration (FDA). Published: 5/14/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Aptima ® SARS-CoV-2 assay, which received an Emergency Use Authorization from the Food and Drug Administration on May 14, 2020. The Aptima® SARS-CoV-2 assay is authorized for use on respiratory specimens collected from individuals meeting COVID-19 clinical and/or epidemiological criteria. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news